• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制定并验证一种列线图模型预测上皮性卵巢癌患者静脉血栓栓塞风险的概率。

Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.

机构信息

Department of Gynecological Oncology, 56713Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, 56713Sun Yat-sen University, Guangzhou, China.

出版信息

Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221095558. doi: 10.1177/10760296221095558.

DOI:10.1177/10760296221095558
PMID:35549519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9112682/
Abstract

To identify predictive factors and develop a nomogram to predict the probability of venous thromboembolism for epithelial ovarian cancer patients. Our study cohort was composed of 208 EOC patients who had received initial treatment in Sun Yat-sen Memorial Hospital from January 2016 to March 2020. Clinicopathological variables predictive of VTE were identified using univariate logistic analysis. A multivariate logistic regression model was used to select the predictive factors used for nomogram. The accuracy of nomogram was evaluated by the Concordance index (C-index), the area under the receiver-operator characteristic (ROC) curve, area under concentration-time curve (AUC) and the calibration curve. Advancing age (hazard ratio [HR], 1.042; 95% confidence interval [CI], 1.000-1.085;  = .048), higher D-dimer level (HR, 1.144; 95%CI, 1.020-1.283;  = .022), lower PR immunohistochemical positive rate (HR, 0.186; 95%CI, 0.034-1.065;  = .059) and higher Ki67 immunohistochemical positive rate (HR, 4.502; 95%CI, 1.637-12.380;  = .004) were found to be independent risk factors for VTE, and were used to construct the nomogram. The C-index for VTE prediction of the nomogram was 0.75. We constructed and validated a nomogram able to quantify the risk of VTE for EOC patients, which can be applied in recognizing EOC patients with high risk of VTE.

摘要

为了确定上皮性卵巢癌患者静脉血栓栓塞的预测因素并建立预测模型。我们的研究队列由 208 名在中山大学孙逸仙纪念医院接受初始治疗的上皮性卵巢癌患者组成,入组时间为 2016 年 1 月至 2020 年 3 月。采用单因素 logistic 分析确定预测 VTE 的临床病理变量。使用多因素 logistic 回归模型选择预测模型的预测因素。通过一致性指数(C 指数)、接受者操作特征曲线下面积(ROC 曲线下面积)、浓度-时间曲线下面积(AUC)和校准曲线评估预测模型的准确性。高龄(风险比 [HR],1.042;95%置信区间 [CI],1.000-1.085; = .048)、较高的 D-二聚体水平(HR,1.144;95%CI,1.020-1.283; = .022)、较低的 PR 免疫组化阳性率(HR,0.186;95%CI,0.034-1.065; = .059)和较高的 Ki67 免疫组化阳性率(HR,4.502;95%CI,1.637-12.380; = .004)是 VTE 的独立危险因素,并用于构建预测模型。该预测模型预测 VTE 的 C 指数为 0.75。我们构建并验证了一个能够量化上皮性卵巢癌患者 VTE 风险的预测模型,该模型可用于识别 VTE 风险较高的上皮性卵巢癌患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a1/9112682/d741e696bccb/10.1177_10760296221095558-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a1/9112682/0ae008d89fa1/10.1177_10760296221095558-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a1/9112682/9d3d794a68d7/10.1177_10760296221095558-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a1/9112682/d741e696bccb/10.1177_10760296221095558-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a1/9112682/0ae008d89fa1/10.1177_10760296221095558-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a1/9112682/9d3d794a68d7/10.1177_10760296221095558-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a1/9112682/d741e696bccb/10.1177_10760296221095558-fig3.jpg

相似文献

1
Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.制定并验证一种列线图模型预测上皮性卵巢癌患者静脉血栓栓塞风险的概率。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221095558. doi: 10.1177/10760296221095558.
2
Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer.制定并验证了一个列线图模型,用于评估 IA 期非小细胞肺癌患者术后静脉血栓栓塞风险。
Cancer Med. 2023 Jan;12(2):1217-1227. doi: 10.1002/cam4.4982. Epub 2022 Jun 27.
3
Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.构建和验证预测 HGSOC 患者术后静脉血栓栓塞风险的列线图。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241255958. doi: 10.1177/10760296241255958.
4
Development and validation of a nomogram model for predicting venous thromboembolism risk in lung cancer patients treated with immune checkpoint inhibitors: A cohort study in China.开发并验证一种列线图模型,用于预测接受免疫检查点抑制剂治疗的肺癌患者发生静脉血栓栓塞风险:中国的一项队列研究。
Cancer Med. 2024 Aug;13(16):e70115. doi: 10.1002/cam4.70115.
5
Nomogram for predicting venous thromboembolism after spinal surgery.脊柱手术后静脉血栓栓塞预测的列线图。
Eur Spine J. 2024 Mar;33(3):1098-1108. doi: 10.1007/s00586-023-08043-2. Epub 2023 Dec 28.
6
A nomogram for predicting the risk of venous thromboembolism in patients with solid cancers.实体瘤患者静脉血栓栓塞风险预测列线图
J Thromb Thrombolysis. 2023 Oct;56(3):414-422. doi: 10.1007/s11239-023-02856-0. Epub 2023 Jul 18.
7
Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study.基于列线图的肺癌住院患者静脉血栓栓塞症新型风险评估模型的推导、验证与评估:一项回顾性病例对照研究
Front Oncol. 2022 Oct 10;12:988287. doi: 10.3389/fonc.2022.988287. eCollection 2022.
8
A nomogram to predict the risk of venous thromboembolism in patients with colon cancer in China.用于预测中国结肠癌患者静脉血栓栓塞风险的列线图。
Cancer Med. 2024 May;13(9):e7231. doi: 10.1002/cam4.7231.
9
Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.韩国上皮性卵巢癌患者接受标准治疗后的静脉血栓栓塞发生率。
Cancer Med. 2021 Mar;10(6):2045-2053. doi: 10.1002/cam4.3797. Epub 2021 Feb 26.
10
Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.组织因子途径抑制剂 2:预测上皮性卵巢癌患者无症状静脉血栓栓塞的新型生物标志物。
Gynecol Obstet Invest. 2022;87(2):133-140. doi: 10.1159/000524804. Epub 2022 May 25.

引用本文的文献

1
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.基线止血生物标志物评估可识别出化疗期间发生静脉血栓栓塞高风险的乳腺癌患者。
Cancers (Basel). 2025 Aug 20;17(16):2712. doi: 10.3390/cancers17162712.
2
Mapping the clinical topography and progression of venous thromboembolism in Chinese breast cancer surgical patients: a prospective longitudinal study.绘制中国乳腺癌手术患者静脉血栓栓塞的临床地形图及进展:一项前瞻性纵向研究。
Breast Cancer. 2025 Jul 24. doi: 10.1007/s12282-025-01748-w.
3
High preoperative D-dimer increases the risk of venous thromboembolism after gynecological tumor surgeries: a meta-analysis of cohort studies.

本文引用的文献

1
Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.妇科癌症女性静脉血栓栓塞症的发生率及相关因素。
Thromb Res. 2020 Jan;185:49-54. doi: 10.1016/j.thromres.2019.11.009. Epub 2019 Nov 13.
2
Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.上皮性卵巢癌中的静脉血栓栓塞症。一项前瞻性队列研究。
Thromb Res. 2019 Sep;181:112-119. doi: 10.1016/j.thromres.2019.07.027. Epub 2019 Aug 2.
3
Prognostic value of progesterone receptor expression in tubo-ovarian high-grade serous carcinoma of the COEUR cohort.
术前D-二聚体水平升高增加妇科肿瘤手术后静脉血栓栓塞的风险:一项队列研究的荟萃分析
Res Pract Thromb Haemost. 2025 Jan 28;9(2):102690. doi: 10.1016/j.rpth.2025.102690. eCollection 2025 Feb.
4
Development and validation of a nomogram for predicting venous thromboembolism risk in post-surgery patients with cervical cancer.预测宫颈癌术后患者静脉血栓栓塞风险的列线图的开发与验证
World J Surg Oncol. 2024 Dec 31;22(1):354. doi: 10.1186/s12957-024-03649-2.
5
A nomogram predicting venous thromboembolism risk in primary liver cancer patients.一种预测原发性肝癌患者静脉血栓栓塞风险的列线图。
J Thromb Thrombolysis. 2025 Jan;58(1):145-156. doi: 10.1007/s11239-024-03041-7. Epub 2024 Sep 21.
6
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention.妇科癌症与静脉血栓栓塞症:一篇旨在提高认识、改善风险评估与预防的叙述性综述
Cancers (Basel). 2024 May 3;16(9):1769. doi: 10.3390/cancers16091769.
7
Nomogram model combined thrombelastography for venous thromboembolism risk in patients undergoing lung cancer surgery.列线图模型联合血栓弹力图评估肺癌手术患者静脉血栓栓塞风险
Front Physiol. 2023 Dec 14;14:1242132. doi: 10.3389/fphys.2023.1242132. eCollection 2023.
8
Development and validation of a nomogram model for predicting the risk of venous thromboembolism in lymphoma patients undergoing chemotherapy: a prospective cohort study conducted in China.在中国开展的前瞻性队列研究:开发和验证用于预测化疗淋巴瘤患者静脉血栓栓塞风险的列线图模型。
Ann Med. 2023;55(2):2275665. doi: 10.1080/07853890.2023.2275665. Epub 2023 Dec 22.
9
Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer.肺癌患者静脉血栓栓塞风险的列线图预测
Cancer Cell Int. 2023 Mar 5;23(1):40. doi: 10.1186/s12935-023-02882-1.
孕酮受体表达在COEUR队列的输卵管卵巢高级别浆液性癌中的预后价值
Histopathology. 2019 Mar;74(4):663-666. doi: 10.1111/his.13784. Epub 2019 Jan 15.
4
Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer.雌激素受体β与卵巢癌相关基因的表达和生存相关。
BMC Cancer. 2018 Oct 16;18(1):981. doi: 10.1186/s12885-018-4898-0.
5
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.一种癌症相关静脉血栓栓塞的临床预测模型:在两个独立前瞻性队列中的开发与验证研究
Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7.
6
Risk factors for deep venous thrombosis in women with ovarian cancer.卵巢癌女性深静脉血栓形成的危险因素。
Medicine (Baltimore). 2018 Jun;97(23):e11009. doi: 10.1097/MD.0000000000011009.
7
Ki67 targeted strategies for cancer therapy.Ki67 靶向治疗策略在癌症治疗中的应用。
Clin Transl Oncol. 2018 May;20(5):570-575. doi: 10.1007/s12094-017-1774-3. Epub 2017 Oct 20.
8
Age-related diagnostic value of D-dimer testing and the role of inflammation in patients with suspected deep vein thrombosis.年龄相关性 D-二聚体检测的诊断价值及炎症在疑似深静脉血栓患者中的作用。
Sci Rep. 2017 Jul 4;7(1):4591. doi: 10.1038/s41598-017-04843-x.
9
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.与乳腺癌、结直肠癌、肺癌或卵巢癌相关的血栓形成的预测评分:前瞻性 COMPASS-癌症相关血栓形成研究。
Oncologist. 2017 Oct;22(10):1222-1231. doi: 10.1634/theoncologist.2016-0414. Epub 2017 May 26.
10
Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.孕激素受体表达在卵巢癌中的预后价值:一项荟萃分析。
Oncotarget. 2017 May 30;8(22):36845-36856. doi: 10.18632/oncotarget.15982.